Higher levels of von Willebrand factor in patients with syncope due to orthostatic hypotension

被引:14
|
作者
Isma, Nazim [1 ,2 ]
Sutton, Richard [3 ]
Hillarp, Andreas [4 ]
Strandberg, Karin [4 ]
Melander, Olle [2 ]
Fedorowski, Artur [1 ,2 ]
机构
[1] Lund Univ, Clin Res Ctr, Skane Univ Hosp, Dept Cardiol, Malmo, Sweden
[2] Lund Univ, Clin Res Ctr, Skane Univ Hosp, Dept Clin Sci, Malmo, Sweden
[3] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England
[4] Skane Univ Hosp, Ctr Thrombosis & Haemostasis, S-20502 Malmo, Sweden
基金
英国医学研究理事会; 欧洲研究理事会;
关键词
MALMO PREVENTIVE PROJECT; CORONARY-HEART-DISEASE; ATHEROSCLEROSIS RISK; CARDIOVASCULAR-DISEASE; PREDICTS MORTALITY; SHEAR-STRESS; COMMUNITIES; MANAGEMENT; ATTACKS; ADULTS;
D O I
10.1097/HJH.0000000000000595
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objectives: Orthostatic hypotension has been linked with increased mortality and cardiovascular morbidity; however, the underlying mechanisms are still unknown. The aim of the study was to assess markers of coagulability in patients with and without orthostatic hypotension who suffered transient loss of consciousness. Methods: A total of 233 consecutive patients more than 15 years old, with unexplained transient loss of consciousness, underwent head-up tilt test (HUT, Italian protocol). Blood samples were collected during supine rest before and at 3 min of 70 degrees HUT for determination of fibrinogen, von Willebrand factor antigen (vWF:Ag) and activity (vWF:GP1bA), factor VIII (FVIII:C), lupus anticoagulant, and functional activated protein C-resistance. Orthostatic hypotension was defined as persistent decrease in SBP and/or DBP of more than 20/10 mmHg or SBP lower than 90 mmHg during passive HUT. Results: One hundred and seventy-eight patients (81 men, 45.5%) not treated with vitamin-K antagonists were analyzed. Those with orthostatic hypotension (n = 49) were older [61 +/- 18 vs. 47 +/- 21 years (mean +/- SD), P < 0.001], had increased FVIII:C-supine (1.2 +/- 0.39 vs. 1.0 +/- 0.35, P = 0.001), FVIII:C-standing (1.2 +/- 0.36 vs. 1.0 +/- 0.34, P = 0.001), vWF:Ag-supine (1.5 +/- 0.66 vs. 1.1 +/- 0.44, P < 0.001), vWF:Ag-standing (1.5 +/- 0.67 vs. 1.1 +/- 0.46, P < 0.001), vWF:GP1bA-supine (1.5 +/- 0.73 vs. 1.1 +/- 0.42, P < 0.001), vWF:GP1bA-standing (1.5 +/- 0.75 vs. 1.1 +/- 0.42 P < 0.001), fibrinogen-standing (2.9 +/- 0.53 vs. 2.7 +/- 0.61, P = 0.03) but not fibrinogen-supine (2.8 +/- 0.54 vs. 2.7 +/- 0.61, P = 0.078) compared with patients without orthostatic hypotension. However, after adjustment for age, sex, and comorbidity, only vWF:Ag and vWF:GP1bA levels remained significantly increased in orthostatic hypotension patients. Conclusion: Concentration of vWF is elevated in patients with orthostatic hypotension who suffered a syncopal event. This observation may be helpful in understanding the increased risk of cardiovascular events in orthostatic hypotension.
引用
收藏
页码:1594 / 1601
页数:8
相关论文
共 50 条
  • [31] Variation in the von Willebrand factor gene is associated with von Willebrand factor levels and with the risk for cardiovascular disease
    van Schie, Marianne C.
    de Maat, Moniek P. M.
    Isaacs, Aaron
    van Duijn, Cornelia M.
    Deckers, Jaap W.
    Dippel, Diederik W. J.
    Leebeek, Frank W. G.
    BLOOD, 2011, 117 (04) : 1393 - 1399
  • [32] Von willebrand factor antigen and factor XI activity levels as predictors of bleeding tendency in Israeli patients with von willebrand's disease
    Brenner, B
    Steinberg, T
    Laor, A
    Tavori, S
    Tatarsky, I
    Lanir, N
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1995, 1 (04) : 260 - 264
  • [33] Effect of tamoxifen on von Willebrand factor levels
    Ounnoughene, N
    Molho, P
    Stieltjes, N
    Sultan, Y
    ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (14) : 1613 - 1613
  • [34] The prevalence and clinical features of menorrhagia patients with abo-adjusted subnormal von Willebrand factor levels versus "borderline" low von Willebrand factor levels
    Kouides, P
    Phatak, P
    Sham, RL
    Braggins, C
    Miller, G
    Cox, C
    Howard, F
    THROMBOSIS AND HAEMOSTASIS, 1999, : 511 - 511
  • [35] Annexin A2 SNP regulates plasma von Willebrand factor levels and is enriched in patients with von Willebrand disease
    Van Heerde, W.
    Kloots, I
    van Puffelen, J.
    van Duren, C.
    Schoormans, S.
    Brons, P.
    van Gorkom, B. L.
    Kiemeney, L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 754 - 754
  • [36] Impact of annexin A2 SNP on von Willebrand factor levels in patients with moderate and severe von Willebrand disease
    Van Heerde, W.
    van Puffelen, J.
    Kloots, I
    Boender, J.
    Sanders, Y.
    Cnossen, M.
    Laros-van Gorkom, B.
    Fijnvandraat, K.
    Schoormans, S.
    van der Bom, J.
    Meijer, K.
    Mauser-Bunschoten, E.
    Eikenboom, J.
    Kiemeney, L.
    Leebeek, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 172 - 173
  • [37] Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age-related increase of VWF in von Willebrand disease
    Atiq, Ferdows
    Meijer, Karina
    Eikenboom, Jeroen
    Fijnvandraat, Karin
    Mauser-Bunschoten, Eveline P.
    van Galen, Karin P. M.
    Nijziel, Marten R.
    Ypma, Paula F.
    de Meris, Joke
    Laros-van Gorkom, Britta A. P.
    van der Bom, Johanna G.
    de Maat, Moniek P.
    Cnossen, Marjon H.
    Leebeek, Frank W. G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (01) : 93 - 105
  • [38] Association of malaria severity with von Willebrand factor and von Willebrand factor propeptide levels and blood group.
    Donkor, C
    Hollestelle, MJ
    Akoto, AO
    O'Donnell, J
    van Mourik, JA
    Bunn, J
    BLOOD, 2003, 102 (11) : 71B - 71B
  • [39] Effect of glucocorticoids on von Willebrand factor levels and its correlation with von Willebrand factor gene promoter polymorphism
    Chopra, Anita
    Kumar, Rajive
    Kishore, Kamal
    Tandon, Nikhil
    Yusuf, Tanveer
    Kumar, Suman
    Mishra, Pravas
    Saxena, Renu
    BLOOD COAGULATION & FIBRINOLYSIS, 2012, 23 (06) : 514 - 519
  • [40] Changes in the levels of factor VIII and von Willebrand factor in the puerperium
    Huq, F. Y.
    Kulkarni, A.
    Agbim, E. C.
    Riddell, A.
    Tuddenham, E.
    Kadir, R. A.
    HAEMOPHILIA, 2012, 18 (02) : 241 - 245